RIVERSIDE MED PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: M82006 | SHREWSBURY, SY1 1QJ
Showing results 451-500 of 578
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Bempedoic acid/Ezetimibe | 22 | 784 | £1.5K | -64.0% ▼ |
| Oxcarbazepine | 22 | 1,336 | £623 | -21.3% ▼ |
| Tibolone | 22 | 1,372 | £125 | -28.1% ▼ |
| 22 | 620 | £232 | -24.0% ▼ | |
| 22 | 1,098 | £209 | -25.1% ▼ | |
| Amiodarone hydrochloride | 21 | 1,176 | £65 | -67.4% ▼ |
| Potassium chloride | 21 | 1,340 | £94 | +12.3% ▲ |
| Timolol and travoprost | 21 | 88 | £288 | -35.0% ▼ |
| Permethrin | 21 | 990 | £264 | -44.3% ▼ |
| 21 | 2,000 | £96 | -61.3% ▼ | |
| 21 | 720 | £87 | -21.8% ▼ | |
| Acetylcysteine | 20 | 810 | £1.2K | -72.0% ▼ |
| Opicapone | 20 | 600 | £1.2K | +4.5% ▲ |
| Zinc oxide | 20 | 4,730 | £138 | -0.5% vs avg |
| 20 | 2,020 | £31 | +18.4% ▲ | |
| Colesevelam hydrochloride | 19 | 4,320 | £1.7K | -49.9% ▼ |
| Chlorpromazine hydrochloride | 19 | 784 | £478 | -51.7% ▼ |
| Amantadine hydrochloride | 19 | 1,428 | £263 | -31.8% ▼ |
| Fosfomycin trometamol | 19 | 23 | £106 | -33.2% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 19 | 24.5K | £378 | -17.1% ▼ |
| 19 | 187 | £594 | -10.1% ▼ | |
| Fluvastatin sodium | 18 | 644 | £90 | -22.2% ▼ |
| Sulpiride | 18 | 5,346 | £3.1K | -32.8% ▼ |
| Liothyronine sodium | 18 | 896 | £2.1K | -15.6% ▼ |
| Apraclonidine | 18 | 109 | £287 | +42.9% ▲ |
| Light liquid paraffin | 18 | 7,600 | £133 | -47.1% ▼ |
| 18 | 230 | £1.4K | +17.4% ▲ | |
| 18 | 1,220 | £388 | +3.1% ▲ | |
| Amiloride hydrochloride | 17 | 588 | £290 | -32.5% ▼ |
| Valsartan | 17 | 952 | £187 | -71.1% ▼ |
| Itraconazole | 17 | 633 | £274 | +26.7% ▲ |
| Norethisterone | 17 | 744 | £127 | -65.0% ▼ |
| Sodium chloride | 17 | 1,532 | £139 | -28.2% ▼ |
| Celecoxib | 17 | 2,164 | £208 | -74.3% ▼ |
| Acetazolamide | 17 | 1,428 | £56 | -21.5% ▼ |
| Tacrolimus | 17 | 660 | £484 | -68.5% ▼ |
| Diclofenac sodium | 17 | 1,150 | £837 | -29.1% ▼ |
| 17 | 1,375 | £2.0K | -7.6% ▼ | |
| 17 | 31 | £3.0K | -52.4% ▼ | |
| 17 | 810 | £742 | -58.1% ▼ | |
| Nebivolol | 16 | 784 | £151 | -84.9% ▼ |
| Atomoxetine hydrochloride | 16 | 476 | £1.1K | -52.7% ▼ |
| Nefopam hydrochloride | 16 | 1,380 | £58 | -85.9% ▼ |
| Dulaglutide | 16 | 64 | £1.2K | -86.0% ▼ |
| Olopatadine | 16 | 140 | £124 | -63.5% ▼ |
| Hepatitis B | 16 | 16 | £193 | +51.2% ▲ |
| 16 | 161 | £1.6K | -8.9% ▼ | |
| 16 | 15.7K | £567 | -58.0% ▼ | |
| 16 | 660 | £3.2K | +30.5% ▲ | |
| Balsalazide sodium | 15 | 3,900 | £867 | +0.7% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.